Apex1 safeguards genomic stability to ensure a cytopathic T cell fate in autoimmune disease models
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci183671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Xiang Xiao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Immunobiology and Transplant Science Center and Department of Surgery. Hauptthemen laut MEDLINE: DNA-(Apurinic or Apyrimidinic Site) Lyase, Genomic Instability, Autoimmune Diseases, T-Lymphocytes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
T cells have a remarkable capacity to clonally expand, a process that is intricately linked to their effector activities. As vigorously proliferating T cell also incur substantial DNA lesions, how the dividing T cells safeguard their genomic integrity to allow the generation of T effector cells remains largely unknown. Here we report the identification of the apurinic/apyrimidinic endonuclease-1 (Apex1) as an indispensable molecule for the induction of cytopathic T effectors in mouse models. We demonstrate that conditional deletion of Apex1 in T cells resulted in a remarkable accumulation of baseless DNA sites in the genome of proliferating T cells, which further led to genomic instability and apoptotic cell death. Consequently, Apex1- deleted T cells failed to acquire any effector features after activation and failed to mediate autoimmune diseases and allergic tissue damages. Detailed mutational analyses pinpointed the importance of its endonuclease domain in the generation of T effector cells. We provide further evidence that inhibiting the base repair activities of Apex1 with chemical inhibitors similarly abrogated the induction of autoimmune diseases. Collectively, our study suggests that Apex1 serves as a gatekeeper for the generation of cytopathic T cells and that therapeutically targeting Apex1 may have important clinical implications in the treatment of autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunobiology and Transplant Science Center and Department of Surgery.
- Department of Cardiovascular Sciences, and.
- J.C. Walter Jr. Transplant Center and Conover Center for Liver Diseases and Transplantation, Houston Methodist Hospital, Houston, Texas, USA.
- Department of Surgery, Weill Cornell Medical College of Cornell University, New York, New York, USA.
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Xiao, X., Du, Y., Sun, S., Su, X., Xing, J., Wang, G., Elzein, S. M., Zou, D., Minze, L. J., Mao, Z., Ghobrial, R. M., Connor, A. A., Chen, W., Zhang, Z., & Li, X. C. (2025). Apex1 safeguards genomic stability to ensure a cytopathic T cell fate in autoimmune disease models. Journal of Clinical Investigation. https://doi.org/10.1172/jci183671
Vancouver
Xiao X, Du Y, Sun S, Su X, Xing J, Wang G, et al. Apex1 safeguards genomic stability to ensure a cytopathic T cell fate in autoimmune disease models. Journal of Clinical Investigation. 2025. doi:10.1172/jci183671
BibTeX
@article{Xiao2025,
author = {Xiao, Xiang and Du, Yong and Sun, Si and Su, Xiaojun and Xing, Junji and Wang, Guangchuan and Elzein, Steven M and Zou, Dawei and Minze, Laurie J and Mao, Zhuyun and Ghobrial, Rafik M and Connor, Ashton A and Chen, Wenhao and Zhang, Zhiqiang and Li, Xian C},
title = {Apex1 safeguards genomic stability to ensure a cytopathic T cell fate in autoimmune disease models},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci183671}
}
EUVIMED